Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-17

Clinical Trial Update: Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis

View source ↗

Summary

Clinical trial update on MRI and biomarkers in golimumab-treated patients with axial spondyloarthritis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Golimumab (golimumab)

Snippet

Sponsor: Professor Mikkel Østergaard | Conditions: Axial Spondyloarthritis | Status: COMPLETED | Results posted: 2020-08-17